Corneal Cross-Linking (CXL)

🎉 ZeeKwat Eye Hospital has successfully performed the first Corneal Cross-Linking (CXL) case, marking an important milestone in Myanmar's Private Eye Hospital Sector.

Corneal Cross-Linking (CXL) is a minimally invasive treatment designed to strengthen and stabilize the cornea in conditions such as progressive Keratoconus.

CXL uses Riboflavin (Vitamin B2) eye drops together with controlled UV-A light to create stronger bonds between the collagen fibers within the cornea. This helps strengthen the corneal structure and slow the progression of the disease.

How Does CXL Work?

- Riboflavin eye drops are applied to the cornea.

- The cornea is exposed to controlled UV-A light.

- The combination activates a photochemical reaction that strengthens the collagen fibers.

- The strengthened cornea becomes more stable, helping to slow or prevent further progression of corneal weakening.

CXL is a stabilizing treatment — it is not designed to return the cornea to its original shape.

Who is an Ideal Candidate for CXL?

CXL is primarily considered for patients with progressive Keratoconus or corneal ectasia where the cornea is becoming progressively weaker or more irregular.

You may be a suitable candidate if you:

- Have progressive Keratoconus

- Show changes in corneal shape or thickness over time

- Have increasing myopia or astigmatism

- Experience changes in vision or glasses prescription

- Have sufficient corneal thickness and overall eye health for the planned treatment

A comprehensive corneal examination, including corneal topography or tomography, is essential to determine whether CXL is appropriate for you.

Your Trusted Eye Care Partner 🦉

ZeeKwek Eye Hospital (Pansodan)

📍 No. 542/544, Corner of Pansodan Street and Merchant Road (In front of the Indian Embassy), Kyauktada Township, Yangon.

☎️ 09 896040106, 09 896040107
💬 Via Viber +959 8960 40108

#zeekwek #eyehospital #cornealcrosslinking #cornea #CXL